Publisher: Science and Education Publishing   (Total: 75 journals)   [Sort by number of followers]

Showing 1 - 75 of 75 Journals sorted alphabetically
American J. of Applied Mathematics and Statistics     Open Access   (Followers: 15)
American J. of Applied Psychology     Open Access   (Followers: 55)
American J. of Biomedical Research     Open Access   (Followers: 2)
American J. of Cancer Prevention     Open Access   (Followers: 12)
American J. of Civil Engineering and Architecture     Open Access   (Followers: 43)
American J. of Clinical Medicine Research     Open Access   (Followers: 8)
American J. of Educational Research     Open Access   (Followers: 70)
American J. of Electrical and Electronic Engineering     Open Access   (Followers: 28)
American J. of Energy Research     Open Access   (Followers: 11)
American J. of Environmental Protection     Open Access   (Followers: 9)
American J. of Epidemiology and Infectious Disease     Open Access   (Followers: 21)
American J. of Food and Nutrition     Open Access   (Followers: 58)
American J. of Food Science and Technology     Open Access   (Followers: 12)
American J. of Infectious Diseases and Microbiology     Open Access   (Followers: 31)
American J. of Information Systems     Open Access   (Followers: 7)
American J. of Materials Engineering and Technology     Open Access   (Followers: 5)
American J. of Materials Science and Engineering     Open Access   (Followers: 8)
American J. of Mathematical Analysis     Open Access   (Followers: 2)
American J. of Mechanical Engineering     Open Access   (Followers: 58)
American J. of Medical and Biological Research     Open Access   (Followers: 10)
American J. of Medical Case Reports     Open Access   (Followers: 3)
American J. of Medical Sciences and Medicine     Open Access   (Followers: 5)
American J. of Medicine Studies     Open Access   (Followers: 3)
American J. of Microbiological Research     Open Access   (Followers: 3)
American J. of Modeling and Optimization     Open Access   (Followers: 2)
American J. of Nanomaterials     Open Access   (Followers: 7)
American J. of Numerical Analysis     Open Access   (Followers: 3)
American J. of Nursing Research     Open Access   (Followers: 6)
American J. of Pharmacological Sciences     Open Access   (Followers: 2)
American J. of Public Health Research     Open Access   (Followers: 27)
American J. of Rural Development     Open Access   (Followers: 7)
American J. of Sensor Technology     Open Access   (Followers: 4)
American J. of Sports Science and Medicine     Open Access   (Followers: 38)
American J. of Water Resources     Open Access   (Followers: 13)
American J. of Zoological Research     Open Access   (Followers: 2)
Applied Ecology and Environmental Sciences     Open Access   (Followers: 25)
Applied Mathematics and Physics     Open Access   (Followers: 3)
Automatic Control and Information Sciences     Open Access   (Followers: 3)
Biomedical Science and Engineering     Open Access   (Followers: 7)
Chemical Engineering and Science     Open Access   (Followers: 47)
Intl. J. of Celiac Disease     Open Access   (Followers: 3)
Intl. J. of Dental Sciences and Research     Open Access   (Followers: 1)
Intl. J. of Econometrics and Financial Management     Open Access   (Followers: 7)
Intl. J. of Physics     Open Access   (Followers: 12)
Intl. Transaction of Electrical and Computer Engineers System     Open Access   (Followers: 2)
J. of Automation and Control     Open Access   (Followers: 8)
J. of Biomedical Engineering and Technology     Open Access   (Followers: 1)
J. of Business and Management Sciences     Open Access   (Followers: 1)
J. of Cancer Research and Treatment     Open Access   (Followers: 4)
J. of Computer Networks     Open Access   (Followers: 8)
J. of Computer Sciences and Applications     Open Access  
J. of Environment Pollution and Human Health     Open Access   (Followers: 7)
J. of Finance and Accounting     Open Access   (Followers: 9)
J. of Finance and Economics     Open Access   (Followers: 13)
J. of Food and Nutrition Research     Open Access   (Followers: 11)
J. of Food Security     Open Access   (Followers: 6)
J. of Geosciences and Geomatics     Open Access   (Followers: 2)
J. of Materials Physics and Chemistry     Open Access   (Followers: 5)
J. of Mathematical Sciences and Applications     Open Access   (Followers: 2)
J. of Optoelectronics Engineering     Open Access   (Followers: 4)
J. of Physical Activity Research     Open Access   (Followers: 4)
J. of Polymer and Biopolymer Physics Chemistry     Open Access   (Followers: 9)
Materials Science and Metallurgy Engineering     Open Access   (Followers: 6)
Nanoscience and Nanotechnology Research     Open Access   (Followers: 20)
Physics and Materials Chemistry     Open Access   (Followers: 2)
Research in Plant Sciences     Open Access   (Followers: 1)
Research in Psychology and Behavioral Sciences     Open Access   (Followers: 3)
Sustainable Energy     Open Access   (Followers: 3)
Turkish J. of Analysis and Number Theory     Open Access   (Followers: 1)
Wireless and Mobile Technologies     Open Access   (Followers: 6)
World J. of Agricultural Research     Open Access   (Followers: 2)
World J. of Analytical Chemistry     Open Access   (Followers: 4)
World J. of Chemical Education     Open Access   (Followers: 6)
World J. of Environmental Engineering     Open Access   (Followers: 3)
World J. of Organic Chemistry     Open Access   (Followers: 7)
Similar Journals
Journal Cover
American Journal of Infectious Diseases and Microbiology
Number of Followers: 31  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2328-4056 - ISSN (Online) 2328-4064
Published by Science and Education Publishing Homepage  [75 journals]
  • A Literature Review of Coronavirus Disease 2019 - A Global Pandemic

    • Authors: Yash Kripalani; Tanvi Garude, Isha Budania, Chirag Chheda
      Pages: 45 - 47
      Abstract: Coronavirus disease 2019 (covid-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in Wuhan, China in 2019 and has spread globally since then being declared by the World Health Organization (WHO) as a global pandemic. The general public has very limited knowledge about this virus and hence preventive measures fail, leading to difficulty in its containment. This article focuses on providing detailed information about the nature of this virus and its effects on the human body which will in turn bring about awareness and help in delaying its spread. This can reduce the surge of patients and help the health care system in coping with the outbreak.
      PubDate: 2020-04-19
      DOI: 10.12691/ajidm-8-2-1
      Issue No: Vol. 8, No. 2 (2020)
  • Current Challenges of the 2019-COVID Pandemic: Where We Started, Where We
           Are, and Where do We Go'

    • Authors: Tarek Khedro; George Yaghmour, Giridharan Ramsingh, Bassam Yaghmour
      Pages: 48 - 56
      Abstract: The current outbreak of the 2019 Novel Coronavirus Disease has disrupted the world. Many studies, clinical trials, and updates have been published with the goal of sharing information that will help prepare the world’s healthcare systems for the flood of patients expected to be infected with covid-19. The goal of this literature review is to provide an extensive summary of the most recent reports and studies since the initial outbreak and provide the most up-to-date understanding of the various aspects of covid-19—its spread, diagnosis, risk factors, and currently available and effective treatment strategies—with the hope that researchers and medical practitioners can use this a branching point to other studies that our outlined here. Symptom management is currently the primary strategy that is being implemented for covid-19 treatment, especially in patients who have developed severe disease. Many promising strategies to treat covid-19 are currently being investigated while a vaccine is under development. Anti-inflammatory drugs like sarilumab and antiviral drugs like chloroquine are undergoing clinical trials, and under an emergency protocol of the US FDA, practitioners can use the antibodies from plasma in covid-19 survivors to treat those infected.
      PubDate: 2020-04-19
      DOI: 10.12691/ajidm-8-2-2
      Issue No: Vol. 8, No. 2 (2020)
  • Sero-Prevalence of Anti-Rubella IgG Antibody (Immunity) Among Pregnant
           Women in Rogo, a Semi-Urban Community of Kano State, North Western Nigeria

    • Authors: Isma’ila Balarabe; Azeez-Akande Oyebanji, Rogo Dahiru Lawal, Muhammad Yusuf Sabo, Yusuf Ahmed Mustapha, Amadu Magaji, Abubakar Ja’afaru, Aliyu Mansur
      Pages: 57 - 63
      Abstract: Rubella virus infection (RVI) is, in most cases, a mild disease, but can cause severe defects in developing fetus and new born known as congenital rubella syndrome (CRS) from maternal infection during pregnancy. Rubella remains poorly controlled in many poor-resourced areas (Nigeria inclusive) despite being a vaccine preventable disease. The study aimed to assess the sero-prevalence of anti-rubella IgG antibody (immunity) and level of susceptibility and associated risk factors to rubella virus infection (RVI) among unimmunized pregnant women in a sub-urban setting. It was a hospital-based, cross-sectional descriptive study, conducted in a public general hospital in Rogo, a sub-urban community located in Kano State, Northwest, Nigeria. A total of 174 consented pregnant women [age range, 13-39 years; mean age, 22.3 ± (SD 2.1) years] attending antenatal care (ANC) clinic of a secondary healthcare centre from July to December, 2017 were randomly selected for the study. Information on bio-data, socio-demographic/risk factors and medical history related to previous RVI were obtained via structured questionnaires and hospital records respectively. Blood sample was collected from each study participant and tested for anti-rubella IgG antibody (past exposure) using ELISA technique. Data were analyzed using SPSS statistical software package version 15.0 and Pearson’s Chi-square or Fisher exact test was used for statistical analysis where applicable. A P-value ≤ 0.05 was considered statistically significant. The sero-prevalence of anti-rubella IgG antibody was 93.6% (163 of 174); and rate of susceptibility to RVI among the study population was 6.4% (11 of 174) and were predominant among the study subjects between ages 16 and 25 years in their first trimester of pregnancy. A significant association exists (P
      PubDate: 2020-05-12
      DOI: 10.12691/ajidm-8-2-3
      Issue No: Vol. 8, No. 2 (2020)
  • Understanding COVID-19 - A Molecular Perspective

    • Authors: Michael O. Okpara; Miebaka Jamabo
      Pages: 64 - 74
      Abstract: Coronavirus disease (COVID-19) is an infectious disease caused by a novel coronavirus now identified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV). COVID-19 was first identified in Wuhan, China in December 2019 but has spread globally. As of May 11, 2020, over 4 million people have been infected with over 280,000 deaths reported globally. This pandemic has severely affected the global economy as most countries had to take pro-active measures to curb the spread of the disease by shutting their borders, making this one of the most devastating health crises in the past century. Coronavirus epidemics are not new to the human populace. The severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) caused epidemics in 2002 and 2012, respectively. These three coronaviruses belong to the beta-coronavirus genus. Despite the past experience from the previous coronavirus epidemics, the world was unprepared for this new outbreak. Therefore, it is important to understand the biology of the virus and the possibility of targeting its components for developing therapeutic drugs and vaccines. This review gives an overview of the biology, transmissibility, and genome organization of SARS-CoV-2. Furthermore, we described the available diagnostic, therapeutic and vaccine strategies for COVID-19.
      PubDate: 2020-06-08
      DOI: 10.12691/ajidm-8-2-4
      Issue No: Vol. 8, No. 2 (2020)
  • Carrier Status of Salmonella Species Infection among Students in a
           Tertiarry Institution

    • Authors: Theophilus Kachi Udeani; Veronica Ngozi Emenuga, Favour Chizaram Sunday
      Pages: 75 - 82
      Abstract: Salmonellosis is a major challenge to public health due to its persistence and high rate of recurrence. This study investigated Salmonella infections and associated risk exposures among tertiary students. This cross-sectional study enrolled 100 undergraduate students. Their personal health information and feeding habits were collected using a questionnaire. Fecal specimens were collected and analyzed bacteriologically. The isolates were subjected to antibiotics susceptibility test. Of 100 students enrolled, 38% had Salmonella species. The prevalence rate was Salmonella typhi, 29%, Salmonella. paratyphi A, 6%, and Salmonella enteritidis, 3%. The females accounted for 27% and males 11% of the isolates. The age group of 20-24 years had the highest infection rate. The participants that were not previously diagnosed of Salmonella species infection had a higher carriage rate of 26% than those who were previously diagnosed of typhoid fever (12%), 48% of the students, do not regularly practice hand washing and 63% never had symptoms of typhoid fever. The students patronize food vendors and this accounted for 34% of the Salmonella isolates. Self-medication was associated with the prevalence of Salmonella species (P=0.000; 95% CI). The Salmonella isolates were resistant to Amoxicillin, Cefuroxime and Nitrofurantoin. The carrier rate of Salmonella typhi was high due to antibiotic abuse.
      PubDate: 2020-06-10
      DOI: 10.12691/ajidm-8-2-5
      Issue No: Vol. 8, No. 2 (2020)
  • In vitro and in vivo Evaluation of Antibiotic Combination against Imipenem
           Resistant Acinetobacter baumannii Strains Isolated from Bangladeshi

    • Authors: Bhuiyan Mohammad Mahtab Uddin; Ritu Saha, Zubair Ahmed Ratan, Surovi Era Suchi, S. M. Shamsuzzaman
      Pages: 83 - 87
      Abstract: Acinetobacter baumannii is becoming a common etiological agent of nosocomial infections resulting in septicemia, meningitis, endocarditis, pneumonia, wound, and urinary tract infections within the healthcare setting. There are currently no defined optimal therapies available for multidrug-resistant (MDR) Acinetobacter baumannii infections. We evaluated the efficacy of imipenem, ceftazidime, amikacin and their combinations against imipenem resistant A. baumannii in experimental rat models. We also detected MBL encoding genes such as blaNDM-1, blaVIM and blaIMP and ESBL encoding genes such as blaCTX-M-15 and blaOXA-1 genes by Polymerase chain reaction (PCR). MBL encoding genes such as blaNDM-1 (83.33%), blaVIM (66.67%) and blaIMP (41.67%) and ESBL encoding genes such as blaCTX-M-15 (16.67%) and blaOXA-1 (12.50%) were detected among imipenem resistant Acinetobacter baumannii by PCR. In vitro activities of imipenem, ceftazidime, amikacin, ciprofloxacin, tigecycline and their combinations were tested using agar dilution method. The proportions of synergy observed in imipenem-ceftazidime, imipenem-amikacin, imipenem-ciprofloxacin and amikacin-tigecycline combinations were 25%, 54.17%, 12.50% and 41.67% respectively in vitro. Rat septicaemic models were evaluated using the imipenem resistant A. baumannii strain. Rats were treated with three antimicrobials and their combinations. For the rat model, the efficacies of imipenem, amikacin and imipenem plus ceftazidime and imipenem plus amikacin were assayed. In the septicaemic rat model, compared to the control group, (i) imipenem alone, (ii) ceftazidime alone (iii) imipenem plus ceftazidime (iv) imipenem plus amikacin showed increased sterile blood culture (50%, 16.67%, 66.67% and 83.33%). Imipenem plus amikacin or amikacin plus tigecycline may be appropriate for the treatment against imipenem resistant Acinetobacter baumannii infections.
      PubDate: 2020-06-12
      DOI: 10.12691/ajidm-8-2-6
      Issue No: Vol. 8, No. 2 (2020)
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762

Your IP address:
Home (Search)
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-